Munjal Patel

675 total citations
21 papers, 439 citations indexed

About

Munjal Patel is a scholar working on Pharmacology, Oncology and Epidemiology. According to data from OpenAlex, Munjal Patel has authored 21 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Munjal Patel's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers) and HIV/AIDS drug development and treatment (4 papers). Munjal Patel is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers) and HIV/AIDS drug development and treatment (4 papers). Munjal Patel collaborates with scholars based in United States, Ukraine and Canada. Munjal Patel's co-authors include Jeffrey V. Ravetch, Hidehiro Fukuyama, Kristin V. Tarbell, Anthony Bonito, Maggi Pack, Ralph M. Steinman, A. M. Harper, Kayo Inaba, Sayuri Yamazaki and Mia Talmor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Blood.

In The Last Decade

Munjal Patel

20 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Munjal Patel United States	7	157	143	125	87	77	21	439
Subasree Srinivasan United States	10	82 0.5×	174 1.2×	110 0.9×	150 1.7×	78 1.0×	19	422
Verònica Alba Spain	12	44 0.3×	75 0.5×	40 0.3×	61 0.7×	12 0.2×	21	309
Adaia Albasanz‐Puig Spain	9	53 0.3×	51 0.4×	32 0.3×	100 1.1×	28 0.4×	14	325
Lorena Rodríguez Chile	8	49 0.3×	109 0.8×	80 0.6×	189 2.2×	50 0.6×	13	388
Juergen Loeffler Germany	14	136 0.9×	22 0.2×	50 0.4×	389 4.5×	17 0.2×	22	561
Valeria Bellelli Italy	6	12 0.1×	43 0.3×	29 0.2×	46 0.5×	14 0.2×	9	273
Tanya O’Neal United States	9	64 0.4×	22 0.2×	86 0.7×	76 0.9×	15 0.2×	11	302
PaulS. Lietman United States	5	59 0.4×	24 0.2×	73 0.6×	245 2.8×	8 0.1×	7	408
Julien Senécal Canada	10	147 0.9×	22 0.2×	22 0.2×	140 1.6×	31 0.4×	12	505
Sara A. Murray United States	8	86 0.5×	52 0.4×	56 0.4×	85 1.0×	2 0.0×	8	277

Countries citing papers authored by Munjal Patel

Since Specialization

Citations

This map shows the geographic impact of Munjal Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munjal Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munjal Patel more than expected).

Fields of papers citing papers by Munjal Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munjal Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munjal Patel. The network helps show where Munjal Patel may publish in the future.

Co-authorship network of co-authors of Munjal Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Munjal Patel. A scholar is included among the top collaborators of Munjal Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munjal Patel. Munjal Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishna, Rajesh, Amitava Mitra, Yuen Yi Hon, et al.. (2024). Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers. Clinical Pharmacology & Therapeutics. 116(6). 1412–1432. 6 indexed citations

McCrea, Jacqueline B., Munjal Patel, Yang Liu, et al.. (2024). Pharmacokinetics of Atorvastatin and Metformin after Coadministration with Islatravir in Healthy Adults. The Journal of Clinical Pharmacology. 65(5). 628–636. 1 indexed citations

Bradley, John S., Camilla Tøndel, Emmanuel Roilides, et al.. (2023). Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram‐Negative Bacterial Infections: A Phase 1b, Open‐Label, Single‐Dose Clinical Trial. The Journal of Clinical Pharmacology. 63(12). 1387–1397. 6 indexed citations

Roberts, Jason A., David P. Nicolau, Ignacio Martín‐Loeches, et al.. (2023). Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance. JAC-Antimicrobial Resistance. 5(2). dlad011–dlad011. 10 indexed citations

Patel, Munjal, et al.. (2023). P2.17-07 Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis. Journal of Thoracic Oncology. 18(11). S381–S381. 1 indexed citations

Patel, Munjal, Paul M. Diderichsen, Andy Z. X. Zhu, et al.. (2023). Population Pharmacokinetics and Exposure-Response Analyses to Demonstrate the Link of Causality between ADAMTS13 and the Clinical Effects of Recombinant ADAMTS13 Compared to Plasma-Based Therapies. Blood. 142(Supplement 1). 1260–1260. 2 indexed citations

Scully, Marie, Thomas L. Ortel, Ziqiang Yu, et al.. (2023). Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study. Blood. 142(Supplement 1). 692–692. 5 indexed citations

Matthews, Randolph P., Youfang Cao, Munjal Patel, et al.. (2022). Safety and Pharmacokinetics of Islatravir in Individuals with Severe Renal Insufficiency. Antimicrobial Agents and Chemotherapy. 66(12). e0093122–e0093122. 7 indexed citations

Matthews, Randolph P., Munjal Patel, Stephanie E. Barrett, et al.. (2021). Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial. Nature Medicine. 27(10). 1712–1717. 50 indexed citations

10.

Gounder, Murugesan, Munjal Patel, Nobuyuki Yamamoto, et al.. (2021). 1548P A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma. Annals of Oncology. 32. S1124–S1125. 1 indexed citations

11.

Bradley, John S., Camilla Tøndel, Emmanuel Roilides, et al.. (2021). 1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase 1b, Open-label, Single-Dose Clinical Trial. Open Forum Infectious Diseases. 8(Supplement_1). S671–S671. 3 indexed citations

12.

Malhotra, Jyoti, Yong Lin, Munjal Patel, et al.. (2021). FP03.02 A Phase I Trial of Atezolizumab and Varlilumab in Combination With Radiation in Patients with Metastatic Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(10). S948–S948. 1 indexed citations

13.

Patel, Munjal, Jeanine Ballard, Guoxin Wu, et al.. (2021). In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform. SLAS DISCOVERY. 26(5). 642–654. 4 indexed citations

14.

Patel, Munjal, Francesco Bellanti, David W. Hilbert, et al.. (2021). Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia. Clinical and Translational Science. 15(2). 396–408. 18 indexed citations

15.

Wang, Xiaohong, Na Liu, Yudong Wei, et al.. (2020). A Single- and Multiple-Dose Study To Characterize the Pharmacokinetics, Safety, and Tolerability of Imipenem and Relebactam in Healthy Chinese Participants. Antimicrobial Agents and Chemotherapy. 65(3).

16.

Harb, Wael A., Amita Patnaik, Devalingam Mahalingam, et al.. (2019). A phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours. Annals of Oncology. 30. v175–v175. 4 indexed citations

17.

Gordon, M.S., Monica Mita, Brian I. Rini, et al.. (2015). 354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer. European Journal of Cancer. 51. S72–S72. 3 indexed citations

18.

Siena, Salvatore, Alexander Drilon, Anna F. Farago, et al.. (2015). 29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements. European Journal of Cancer. 51. S724–S725. 9 indexed citations

19.

Yamazaki, Sayuri, Munjal Patel, A. M. Harper, et al.. (2006). Effective expansion of alloantigen-specific Foxp3 ⁺ CD25 ⁺ CD4 ⁺ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proceedings of the National Academy of Sciences. 103(8). 2758–2763. 161 indexed citations

20.

Singhal, Arun, et al.. (1999). Carotid Artery Endarterectomy in the Octogenarian: A Community Hospital Experience. Vascular Surgery. 33(5). 451–460. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact